Clinical Trials Directory

Trials / Unknown

UnknownNCT03228927

Characterization of the Facial and Gut Microbiome in Rosacea

Characterization of the Facial and Gut Microbiome in Identical and Fraternal Twins With Rosacea; Comparison to Healthy Controls

Status
Unknown
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
The Acne Cure Alliance · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Questionnaires will be completed by each member of the twin set. A board-certified dermatologist will examine each member to categorize the type and severity of their rosacea. The facial and gut microbiome will be sampled and sent for microbial analysis.

Detailed description

1. Twin set subjects will be administered a questionnaire regarding demographics (age, gender, state of residence, time lived together, birth order), rosacea duration, prior rosacea treatment, diet (and similarity of diet to twin), co-morbidities, signs and symptoms suggestive of cardiovascular or gastrointestinal disease/disorder. 2. Subjects will be examined by a board-certified dermatologist and global assessment, inflammatory counts and clinician's erythema score will be performed. Eyes will be examined for signs of ocular rosacea. 3. Facial microbiome sampling will be performed on-site utilizing a kit manufactured by UBiome. The skin with active rosacea will be swabbed and the swab immediately placed in sample medium. The tube is then shipped to the manufacturer for 16s rRNA shotgun metagenomics to identify resident bacterial genera and species. (16) This can be compared to their extensive library of normal controls, to the other member of the twin set and to acne subjects. 4. Subjects will be given a fecal microbiome kit for home sampling. Feces obtained from toilet paper is collected and placed in the sample medium. Subjects can either ship directly or return to the study site for shipping.

Conditions

Interventions

TypeNameDescription
OTHERcomparison of twin A to twin BComparison of Twin A to Twin B

Timeline

Start date
2017-08-05
Primary completion
2017-08-06
Completion
2017-08-06
First posted
2017-07-25
Last updated
2017-07-26

Source: ClinicalTrials.gov record NCT03228927. Inclusion in this directory is not an endorsement.